EUVIMEDEUVIMED entdecken
Crossref

Epigenetic Analysis Identifies Molecular Markers of Malignant Potential in ss

Bhuvic Patel, Diane Aum, Sangami Pugazenthi, Miguel Hernandez Rovira, Kaleigh Roberts, Nima Sharifai, Sonika Dahiya, Julie Silverstein, Craig Horbinski, Albert H. Kim, Felix Sahm

Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398

DOI: 10.1055/s-0044-1779938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Bhuvic Patel und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pituitary adenomas occur in approximately 10% of the population and can cause hormonal imbalance and compression of neural structures adjacent to the pituitary gland, most notably the optic nerves and chiasm. Although most adenomas respond favorably to treatment, some adenomas are locally invasive, treatment resistant, or even widely metastatic. To date, however, prognostication of pituitary adenomas remains a controversial topic. Recently, epigenetic analysis has been reliably used to categorize and characterize a wide range of central nervous system tumors and represents a promising new means of understanding the pathophysiology of pituitary adenomas.

Methods

We profiled a total of 228 pituitary adenomas—156 (140 indolent and 16 metastatic) from a multi-institutional, international cohort and 70 adenomas with publicly available data—using Illumina Infinium methylation array analysis. After batch effect correction, probe filtration and normalization, consensus clustering was used to perform unsupervised clustering of a discovery cohort of 140 indolent adenomas. These results were validated by performing similar analyses on the 70 adenomas with publicly available methylation array data. The epigenetic profiles of metastatic carcinomas were then compared to indolent adenomas using dimensionality reduction and enrichment analysis.

Results

Unsupervised clustering accurately clustered the discovery and validation cohort indolent adenomas into groups that first separated into three clusters defined by transcription factor subtype and next into seven clusters defined by hormonal/granulation subtype, mirroring the current World Health Organization classification schema for pituitary adenomas, which is based on immunohistochemical staining for transcription factors and hormones. T-SNE dimensionality reduction analysis corroborated these findings, with adenomas distributing by transcription factor and hormonal subtype. When indolent and metastatic adenomas were combined and subjected to dimensionality reduction analysis, metastatic adenomas distributed by hormonal subtype but remained separate from indolent adenomas. Enrichment analysis of differentially methylated probes between metastatic corticotroph adenomas (the largest subgroup of metastatic adenomas in our study) and indolent corticotroph adenomas revealed hypermethylation of gene loci associated with DNA damage repair, telomere maintenance, DNA damage responses, and other processes typically associated with malignancy by gene ontology analysis.

Conclusions

Epigenetic analysis of pituitary adenomas reliably differentiates from adenomas by their transcription factor and hormonal subtype. Furthermore, epigenetic analysis of pituitary adenoma tissue prior to metastasis provides us with initial insights into the underlying biology of aggressively behaving adenomas. Additional investigation of differentially methylated genes and pathways may reveal prognostic markers or therapeutic targets for aggressive pituitary adenomas. Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Patel, B., Aum, D., Pugazenthi, S., Rovira, M. H., Roberts, K., Sharifai, N., Dahiya, S., Silverstein, J., Horbinski, C., Kim, A. H., & Sahm, F. (2024). Epigenetic Analysis Identifies Molecular Markers of Malignant Potential in ss. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779938

Vancouver

Patel B, Aum D, Pugazenthi S, Rovira MH, Roberts K, Sharifai N, et al. Epigenetic Analysis Identifies Molecular Markers of Malignant Potential in ss. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779938

BibTeX
@article{Patel2024,
  author = {Patel, Bhuvic and Aum, Diane and Pugazenthi, Sangami and Rovira, Miguel Hernandez and Roberts, Kaleigh and Sharifai, Nima and Dahiya, Sonika and Silverstein, Julie and Horbinski, Craig and Kim, Albert H. and Sahm, Felix},
  title = {Epigenetic Analysis Identifies Molecular Markers of Malignant Potential in ss},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2024},
  volume = {85},
  number = {S 01 S 01},
  pages = {S1--S398},
  doi = {10.1055/s-0044-1779938}
}
Kostenlos starten →